Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Rebecca Payne(NIHR Newcastle Biomedical Research Centre), Victoria Hall(Unknown), Síle A. Johnson(Medawar Building for Pathogen Research), Sarah Foulkes(Unknown), Andrew Cross(University of Liverpool), Alexander Hargreaves(Centre for Human Genetics), Thomas Altmann(Great North Children's Hospital), Dan Wootton(University of Liverpool), Alice Bridges-Webb(University of Oxford), Sian Faustini(University of Birmingham), Piyada Supasa(University of Oxford), Ali Amini(University of Oxford), Laura Silva-Reyes(University of Oxford), James Austin(University of Liverpool), Katie Jeffery, Eleanor Barnes(Oxford Health NHS Foundation Trust), Susan Hopkins(National Security Agency), Eloise Phillips(Oxford University Hospitals NHS Trust), Alexander R. Nicols(Newcastle University), Sarah Rowland‐Jones(University of Oxford), Tom Tipton(Centre for Human Genetics), Donal Skelly(John Radcliffe Hospital), John Frater(University of Oxford), Susan L. Dobson(University of Liverpool), Lizzie Stafford, Naomi Meardon(Sheffield Teaching Hospitals NHS Foundation Trust), Jessica K. Tyerman(Newcastle University), Philippa C. Matthews(University College London Hospitals NHS Foundation Trust), Ayoub Saei(Public Health England), Stephanie Longet(Centre for Human Genetics), Gurjinder Sandhar(University of Sheffield), Saly Al‐Taei(University of Birmingham), Alexandra Deeks(University of Oxford), Juthathip Mongkolsapaya(Centre for Human Genetics), Adrian Shields(University Hospitals Birmingham NHS Foundation Trust), Luisa M. Hering(University of Liverpool), Andrew J. Pollard(University of Oxford), Wanwisa Dejnirattisai(Hammersmith Hospital), Adrienn Angyal(University of Sheffield), Natalie Gillson(Public Health England), Sandra Adele(Medawar Building for Pathogen Research), Tom Malone, Rebecca Brown(University of Sheffield), Hailey Hornsby(University of Sheffield), Rachel Whitham(Sheffield Teaching Hospitals NHS Foundation Trust), Shona C. Moore(University of Liverpool), Christopher P. Conlon(Oxford Health NHS Foundation Trust), Jonathan A. Kilby(University of Sheffield), Aline Linder(University of Oxford), Anthony Brown(Centre for Human Genetics)
Cited by 352
Related Papers
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
|The Lancet Infectious Diseases|2018|3k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k